Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Cullinan Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +23 vs. Q1 2024
- Shares held
- 62.9M
- +23.6M (+60.0%) vs. Q1 2024
- Total value
- $1.10B
- +$427.3M (+63.8%) vs. Q1 2024
- New holders
- 39
- 60 more added
- Sold out
- 16
- 26 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CGEM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 183 | $1.30B |
| Q1 2026 | 174 | $931.0M |
| Q4 2025 | 153 | $653.8M |
| Q3 2025 | 145 | $362.2M |
| Q2 2025 | 144 | $471.4M |
| Q1 2025 | 149 | $489.6M |
| Q4 2024 | 147 | $798.8M |
| Q3 2024 | 137 | $1.09B |
| Q2 2024 | 135 | $1.10B |
| Q1 2024 | 113 | $670.8M |
| Q4 2023 | 113 | $375.6M |
| Q3 2023 | 106 | $344.0M |
| Q2 2023 | 106 | $397.3M |
| Q1 2023 | 103 | $329.5M |
| Q4 2022 | 97 | $397.7M |
| Q3 2022 | 100 | $474.7M |
| Q2 2022 | 89 | $481.7M |
| Q1 2022 | 82 | $386.3M |
| Q4 2021 | 75 | $559.7M |
| Q3 2021 | 66 | $762.3M |
| Q2 2021 | 71 | $828.5M |
| Q1 2021 | 70 | $1.30B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Cullinan Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 403,878 | $7.04M | 0.00% | −16,339−3.9% | Reduced |
| Bank of America Corp | 412,745 | $7.20M | 0.00% | +281,396+214.2% | Added |
| Renaissance Technologies LLC | 421,708 | $7.35M | 0.01% | +100,608+31.3% | Added |
| Goldman Sachs Group Inc | 452,787 | $7.90M | 0.00% | +283,420+167.3% | Added |
| Deutsche Bank AG | 555,067 | $9.68M | 0.00% | +5,791+1.1% | Added |
| Twin Focus Capital Partners, LLC | 595,489 | $10.4M | 1.66% | +595,489 | New |
| Boxer Capital, LLC | 657,895 | $11.5M | 0.60% | +657,895 | New |
| Foresite Capital Management V, LLC | 657,905 | $11.5M | 7.33% | +657,905 | New |
| Rock Springs Capital Management LP | 658,338 | $11.5M | 0.35% | +658,338 | New |
| Perceptive Advisors LLC | 749,916 | $13.1M | 0.32% | +749,916 | New |
| Dimensional Fund Advisors LP | 759,760 | $13.2M | 0.00% | −233,617−23.5% | Reduced |
| Morgan Stanley | 838,283 | $14.6M | 0.00% | −314,361−27.3% | Reduced |
| Tang Capital Management LLC | 921,138 | $16.1M | 1.64% | +350,000+61.3% | Added |
| Geode Capital Management, LLC | 976,486 | $17.0M | 0.00% | +299,156+44.2% | Added |
| RTW Investments, LP | 1,052,630 | $18.4M | 0.28% | +1,052,630 | New |
| Artal Group S.A. | 1,057,949 | $18.5M | 0.47% | +1,057,949 | New |
| Cormorant Asset Management, LP | 1,125,000 | $19.6M | 1.14% | +1,125,000 | New |
| OrbiMed Advisors LLC | 1,147,655 | $20.0M | 0.43% | +630,049+121.7% | Added |
| Marshall Wace, LLP | 1,184,037 | $20.6M | 0.03% | +1,136,993+2,416.9% | Added |
| Nextech Invest AG | 1,221,145 | $21.3M | 3.58% | 00.0% | Unchanged |
| Holocene Advisors, LP | 1,316,005 | $23.0M | 0.10% | +1,316,005 | New |
| VR Adviser, LLC | 1,379,965 | $24.1M | 1.53% | +1,379,965 | New |
| Paradigm Biocapital Advisors LP | 1,542,805 | $26.9M | 1.03% | +194,790+14.5% | Added |
| Avidity Partners Management LP | 1,559,826 | $27.2M | 1.16% | +1,559,826 | New |
| Alliancebernstein L.P. | 1,728,545 | $30.1M | 0.01% | +1,695,345+5,106.5% | Added |
| State Street Corp | 1,941,188 | $33.9M | 0.00% | +515,729+36.2% | Added |
| Citadel Advisors LLC | 1,943,139 | $33.9M | 0.03% | +833,968+75.2% | Added |
| Blue Owl Capital Holdings LP | 2,049,172 | $35.7M | 9.94% | −875,670−29.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,232,829 | $38.9M | 0.07% | +1,282,829+135.0% | Added |
| Franklin Resources Inc | 2,444,130 | $42.6M | 0.01% | −252,632−9.4% | Reduced |
| Vanguard Group Inc | 2,871,375 | $50.1M | 0.00% | +1,097,030+61.8% | Added |
| Deerfield Management Company, L.P. (Series C) | 3,280,237 | $57.2M | 0.95% | +2,141,706+188.1% | Added |
| BlackRock Inc. | 3,550,207 | $61.9M | 0.00% | +1,121,214+46.2% | Added |
| BVF Inc | 5,750,683 | $100.3M | 2.81% | +2,553,982+79.9% | Added |
| MPM Oncology Impact Management LP | 7,648,268 | $133.4M | 20.73% | 00.0% | Unchanged |
| Logos Global Management LP | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −626,929−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −178,396−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −84,234−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −60,074−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −55,888−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −36,401−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −21,250−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −20,225−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −16,347−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −12,742−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,286−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,273−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −723−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |